The clinical noncompliance of oral sotalol/magnesium for prophylactic treatment of atrial fibrillation after coronary artery bypass grafting

Journal of Cardiac Surgery

Volumn 22, Issue 4, 2007, Pages 281-286

  Mariscalco, Giovanni ^a,b   Cederlund, Bengt ^c   Engström, Karl Gunnar ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM HYDROXIDE; MAGNESIUM SULFATE; SOTALOL;

AGED; AORTA CLAMPING; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; EVALUATION; FEMALE; HEART ATRIUM FIBRILLATION; HEART SURGERY; HEMODYNAMICS; HUMAN; INOTROPISM; MALE; MORBIDITY; POLICY; POSTOPERATIVE PERIOD; PROPHYLAXIS; SUPPLEMENTATION; THERAPY EFFECT;

ADMINISTRATION, ORAL; AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; FEASIBILITY STUDIES; FEMALE; HUMANS; MAGNESIUM HYDROXIDE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SELECTION BIAS; SOTALOL; STATISTICS; TREATMENT REFUSAL;

EID: 34547461658     PISSN: 08860440     EISSN: 15408191     Source Type: Journal    
DOI: 10.1111/j.1540-8191.2007.00408.x     Document Type: Article

References (24)

1. Hogue CW Jr., Hyder ML : Atrial fibrillation after cardiac operation: Risks, mechanisms, and treatment. Ann Thorac Surg 2000 69 : 300 306.
2. Maisel WH, Rawn JD, Stevenson WG : Atrial fibrillation after cardiac surgery. Ann Intern Med 2001 135 : 1061 1073.
3. Aranki SF, Shaw DP, Adams DH, et al : Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation 1996 94 : 390 397.
4. Mathew JP, Fontes ML, Tudor IC, et al : A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 2004 291 : 1720 1729.
5. Crystal E, Connolly SJ, Sleik K, et al : Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: A meta-analysis. Circulation 2002 106 : 75 80.
6. Shiga T, Wajima Z, Inoue T, et al : Magnesium prophylaxis for arrhythmias after cardiac surgery: A meta-analysis of randomized controlled trials. Am J Med 2004 117 : 325 333.
7. Forlani S, De Paulis R, de Notaris S, et al : Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg 2002 74 : 720 725 discussion 725-726.
8. Geertman H, Van Der Starre PJ, Sie HT, et al : Magnesium in addition to sotalol does not influence the incidence of postoperative atrial tachyarrhythmias after coronary artery bypass surgery. J Cardiothorac Vasc Anesth 2004 18 : 309 312.
9. Suttorp MJ, Kingma JH, Peels HO, et al : Effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass grafting. Am J Cardiol 1991 68 : 1163 1169.
10. Suttorp MJ, Kingma JH, Tjon Joe Gin RM, et al : Efficacy and safety of low- and high-dose sotalol versus propranolol in the prevention of supraventricular tachyarrhythmias early after coronary artery bypass operations. J Thorac Cardiovasc Surg 1990 100 : 921 926.
11. Nystrom U, Edvardsson N, Berggren H, et al : Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery. Thorac Cardiovasc Surg 1993 41 : 34 37.
12. Parikka H, Toivonen L, Heikkila L, et al : Comparison of sotalol and metoprolol in the prevention of atrial fibrillation after coronary artery bypass surgery. J Cardiovasc Pharmacol 1998 31 : 67 73.
13. Weber UK, Osswald S, Huber M, et al : Selective versus non-selective antiarrhythmic approach for prevention of atrial fibrillation after coronary surgery: is there a need for pre-operative risk stratification? A prospective placebo-controlled study using low-dose sotalol. Eur Heart J 1998 19 : 794 800.
14. Evrard P, Gonzalez M, Jamart J, et al : Prophylaxis of supraventricular and ventricular arrhythmias after coronary artery bypass grafting with low-dose sotalol. Ann Thorac Surg 2000 70 : 151 156.
15. Matsuura K, Takahara Y, Sudo Y, et al : Effect of Sotalol in the prevention of atrial fibrillation following coronary artery bypass grafting. Jpn J Thorac Cardiovasc Surg 2001 49 : 614 617.
16. Topf JM, Murray PT : Hypomagnesemia and hypermagnesemia. Rev Endocr Metab Disord 2003 4 : 195 206.
17. Hill LL, De Wet C, Hogue CW : Management of atrial fibrillation after cardiac surgery, Part II: Prevention and treatment. J Cardiothorac Vasc Anesth 2002 16 : 626 637.
18. Antonaccio MJ, Gomoll A : Pharmacology, pharmacodynamics and pharmacokinetics of sotalol. Am J Cardiol 1990 65 : 12A 21A discussion 35A-36A.
19. Hohnloser SH, Zabel M, Krause T, et al : Short- and long-term antiarrhythmic and hemodynamic effects of d,l-sotalol in patients with symptomatic ventricular arrhythmias. Am Heart J 1992 123 : 1220 1224.
20. Hohnloser SH, Woosley RL : Sotalol. N Engl J Med 1994 331 : 31 38.
21. Soyka LF, Wirtz C, Spangenberg RB : Clinical safety profile of sotalol in patients with arrhythmias. Am J Cardiol 1990 65 : 74A 81A discussion 82A-83A.
22. Kulick DL, Hong R, Ryzen E, et al : Electrophysiologic effects of intravenous magnesium in patients with normal conduction systems and no clinical evidence of significant cardiac disease. Am Heart J 1988 115 : 367 373.
23. Schelling JR : Fatal hypermagnesemia. Clin Nephrol 2000 53 : 61 65.
24. Touyz RM : Magnesium in clinical medicine. Front Biosci 2004 9 : 1278 1293.